Declining adherence is a more likely explanation than frailty of the apparent decline in efficacy in the CAPRISA 004 trial: response to O’Hagan et al.

Grobler, Anna Christina.; Abdool Karim, Salim Safurdeen.

Declining adherence is a more likely explanation than frailty of the apparent decline in efficacy in the CAPRISA 004 trial: response to O’Hagan et al.

Files

Grobler_Anneke_2012.pdf (279.13 KB)

Date

2012

Authors

Grobler, Anna Christina.

Abdool Karim, Salim Safurdeen.

Publisher

Lippincott Williams & Wilkins.

Abstract

No abstract available.

Keywords

Clinical trials--Evaluation., HIV infections--Treatment., HIV infections--Drug therapy., Patient compliance.

Citation

Grobler, A., Abdool Karim, S.S. 2012. Declining adherence is a more likely explanation than frailty of the apparent decline in efficacy in the CAPRISA 004 trial: response to O’Hagan et al. AIDS 26 (17) p.2261.

URI

http://dx.doi.org/10.1097/QAD.0b013e328355ce08
http://hdl.handle.net/10413/9195

Collections

Research papers (Caprisa)

Full item page

Declining adherence is a more likely explanation than frailty of the apparent decline in efficacy in the CAPRISA 004 trial: response to O’Hagan et al.

Files

Date

Authors

Journal Title

Journal ISSN

Volume Title

Publisher

Abstract

Description

Keywords

Citation

URI

Collections

Endorsement

Review

Supplemented By

Referenced By